Neoplasms, Glandular and Epithelial  >>  TheraSphere (yttrium 90 microspheres)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TheraSphere (yttrium 90 microspheres) / Boston Scientific
NCT00910572: Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma

Completed
2
60
Europe
Yttrium-90 microspheres (Therasphere MDS Nordion), Therasphere, produced by MDS Nordion, Ottawa, Canada
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Gastro Intestinal Surgery and Liver Transplantation, The Hepato-Oncology Group: Department of Surgery, Medicine and Radiology
Hepatocellular Carcinoma, Liver Cancer
11/09
05/10
NCT01290536: Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases

Completed
2
42
NA
Selective internal radiation therapy to the liver using Yttrium-90 glass microspheres (TheraSphere)
Nicholas Fidelman, MD
Colorectal Neoplasms, Neuroendocrine Tumors, Cholangiocarcinoma, Melanoma, Breast Cancer
10/13
10/13
NCT01177007: Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors

Completed
2
50
US
TheraSphere, Yttrium-90 glass Microspheres
Yale University
Liver Neoplasms
08/14
08/14

Download Options